Nom du produit:butyl4-benzylpiperazine-1-carboxylate
IUPAC Name:butyl 4-benzylpiperazine-1-carboxylate
- CAS：1019928-96-1
- Formule moléculaire：C16H24N2O2
- Pureté：95%+
- Numéro de catalogue：CM1019210
- Poids moléculaire：276.38
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1019928-96-1
- Formule moléculaire:C16H24N2O2
- Point de fusion:-
- Code SMILES:CCCCOC(=O)N1CCN(CC1)CC2=CC=CC=C2
- Densité:
- Numéro de catalogue:CM1019210
- Poids moléculaire:276.38
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Piperazines
- Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.
Column Infos
- Selatogrel
- Selatogrel is an investigational, potent, fast-acting, reversible, and highly selective P2Y12 inhibitor, being developed for the treatment of an acute myocardial infarction (AMI) in patients with a recent history of AMI. It is intended to be self-administered subcutaneously via a drug delivery system (autoinjector).
This novel, self-administered emergency agent has the potential to protect heart muscle in the very early phase of an AMI – in the crucial time between symptom onset and first medical attention – so as to treat the ongoing AMI and prevent early death.
Recherche 
+86 21 5895 0110 
